GlucoSet Overview
- Founded
-
2011

- Status
-
Private
- Employees
-
20

- Latest Deal Type
-
Angel
- Latest Deal Amount
-
$692K
- Investors
-
2
GlucoSet General Information
Description
Developer of a real-time intravascular blood glucose monitoring system designed to reduce harmful hypoglycemia. The company's system delivers continuous and accurate information on the patient's blood glucose level, enabling clinicians to make glucose control in ICUs possible and reduce mortality, complications, and costs.
Contact Information
Website
www.glucoset.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Primary Office
- Sluppenvegen 6
- 7037 Trondheim
- Norway
+47 977 00 000
GlucoSet Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Angel (individual) | 07-Sep-2018 | $692K | 00000 | Completed | Pre-Clinical Trials | |
3. Grant | 24-Feb-2016 | 00.000 | Completed | Pre-Clinical Trials | ||
2. Buyout/LBO | 01-Jan-2015 | Completed | Pre-Clinical Trials | |||
1. Grant | 17-Oct-2014 | $24.8K | Completed | Pre-Clinical Trials |
GlucoSet Executive Team (5)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Nicolas Elvemo | Co-Founder & Chief Executive Officer | ||
Lukas Scherer | Chief Technology Officer | ||
Dag Hjelme | Co-Founder |
GlucoSet Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
Erik Fuglseth Ph.D | Self | Board Member | 000 0000 |
Jan Sollid | Self | Chairman | 000 0000 |
Jørgen Nilsen | Televenture | Board Member | 000 0000 |
Reinold Ellingsen Ph.D | GlucoSet | Board Member | 000 0000 |
Trude Tingvoll | GlucoSet | Board Member | 000 0000 |
GlucoSet Signals
GlucoSet Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Nordic Angel Program | Angel Group | Minority | 000 0000 | 000000 0 | |
Horizon 2020 SME Instrument | Government | 000 0000 | 000000 0 |